Mirion Technologies, Inc. (NYSE:MIR) Stock Has Average Target Price of $25.12

Mirion Technologies, Inc. (NYSE:MIR) has earned a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $25.12.

MIR has been the subject of several recent analyst reports. The Goldman Sachs Group reiterated a “buy” rating and issued a $23.00 target price on shares of Mirion Technologies in a research note on Wednesday, July 29th. Citigroup lowered their price target on Mirion Technologies from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. Weiss Ratings upgraded Mirion Technologies from a “sell (d)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Jefferies Financial Group began coverage on Mirion Technologies in a research report on Thursday, September 3rd. They issued a “buy” rating and a $20.00 price objective for the company. Finally, B. Riley Financial reduced their target price on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Thursday, July 30th.

Mirion Technologies Trading Down 3.3%

NYSE MIR opened at $15.88 on Thursday. The company has a market cap of $3.95 billion, a PE ratio of 34.94 and a beta of 1.10. The company has a current ratio of 3.20, a quick ratio of 2.63 and a debt-to-equity ratio of 0.64. Mirion Technologies has a 12 month low of $14.04 and a 12 month high of $30.28. The stock has a 50 day moving average of $15.61 and a 200-day moving average of $17.07.

Mirion Technologies (NYSE:MIR) last released its earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.02. The business had revenue of $266.80 million during the quarter, compared to analysts’ expectations of $269.32 million. Mirion Technologies had a net margin of 2.39% and a return on equity of 6.59%. The firm’s revenue was up 19.7% on a year-over-year basis. During the same period last year, the business earned $0.11 earnings per share. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. On average, equities research analysts anticipate that Mirion Technologies will post 0.55 EPS for the current fiscal year.

Hedge Funds Weigh In On Mirion Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP raised its position in shares of Mirion Technologies by 14.4% in the first quarter. Dimensional Fund Advisors LP now owns 4,694,288 shares of the company’s stock valued at $87,240,000 after buying an additional 591,730 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Mirion Technologies by 47.4% during the 1st quarter. Bank of New York Mellon Corp now owns 4,536,732 shares of the company’s stock worth $84,338,000 after acquiring an additional 1,459,787 shares during the period. Maverick Capital Ltd. acquired a new position in Mirion Technologies in the 1st quarter valued at $49,261,000. Rockefeller Capital Management L.P. raised its holdings in Mirion Technologies by 17.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 1,139,037 shares of the company’s stock valued at $26,676,000 after acquiring an additional 167,454 shares in the last quarter. Finally, Emerald Advisers LLC lifted its position in shares of Mirion Technologies by 21.5% during the 1st quarter. Emerald Advisers LLC now owns 1,381,574 shares of the company’s stock valued at $25,683,000 after acquiring an additional 244,428 shares during the period. Institutional investors and hedge funds own 78.51% of the company’s stock.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, and analysis solutions for customers operating in highly regulated and safety-sensitive environments. The company develops hardware, software, and services used to monitor radiation, protect personnel, manage nuclear materials, and support compliance with industry and government standards.

Its offerings include radiation detectors and spectrometers, personal dosimetry and health-physics systems, nuclear instrumentation and control equipment, contamination monitoring systems, and related data-management software.